Your browser doesn't support javascript.
loading
Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.
Phillips, Jeffrey S; Da Re, Fulvio; Irwin, David J; McMillan, Corey T; Vaishnavi, Sanjeev N; Xie, Sharon X; Lee, Edward B; Cook, Philip A; Gee, James C; Shaw, Leslie M; Trojanowski, John Q; Wolk, David A; Grossman, Murray.
Afiliação
  • Phillips JS; Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Da Re F; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Irwin DJ; Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
  • McMillan CT; PhD Program in Neuroscience, University of Milano-Bicocca, Milan, Italy.
  • Vaishnavi SN; School of Medicine and Surgery, Milan Center for Neuroscience (NeuroMI), University of Milano-Bicocca, Milan, Italy.
  • Xie SX; Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Lee EB; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Cook PA; Penn Frontotemporal Degeneration Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Gee JC; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Shaw LM; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Trojanowski JQ; Penn Memory Center, University of Pennsylvania, Philadelphia, PA, USA.
  • Wolk DA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Grossman M; Center for Neurodegenerative Disease Research, University of Pennsylvania, Philadelphia, PA, USA.
Brain ; 142(6): 1701-1722, 2019 06 01.
Article em En | MEDLINE | ID: mdl-31135048

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva / Substância Cinzenta Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Alzheimer / Disfunção Cognitiva / Substância Cinzenta Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Brain Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido